STOCK TITAN

Covalon to Present at the Planet MicroCap Showcase: VANCOUVER 2024 in association with Small Cap Discoveries on Thursday, September 26, 2024 at 10:00 a.m. PST

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Covalon Technologies (TSXV:COV, OTCQX:CVALF), an advanced medical technologies company, will be presenting at the Planet MicroCap Showcase: VANCOUVER 2024 in association with Small Cap Discoveries on Thursday, September 26, 2024, at 10:00 AM PST. Brent Ashton, CEO of Covalon, will host the presentation and answer questions.

The live presentation can be accessed via webcast at https://www.webcaster4.com/Webcast/Page/3056/510941. One-on-one meetings will be conducted in person at the Fairmont Waterfront Vancouver. If unable to attend live, the presentation will be available on the conference event platform under the 'Agenda' tab at https://planetmicrocapshowcase.com/agenda.

Covalon Technologies (TSXV:COV, OTCQX:CVALF), un'azienda di tecnologia medica avanzata, presenterà al Planet MicroCap Showcase: VANCOUVER 2024 in associazione con Small Cap Discoveries giovedì 26 settembre 2024, alle 10:00 PST. Brent Ashton, CEO di Covalon, condurrà la presentazione e risponderà alle domande.

La presentazione dal vivo sarà accessibile tramite webcast all'indirizzo https://www.webcaster4.com/Webcast/Page/3056/510941. I colloqui individuali si svolgeranno di persona presso il Fairmont Waterfront Vancouver. Se non si riesce a partecipare di persona, la presentazione sarà disponibile sulla piattaforma dell'evento della conferenza sotto la scheda 'Agenda' all'indirizzo https://planetmicrocapshowcase.com/agenda.

Covalon Technologies (TSXV:COV, OTCQX:CVALF), una empresa de tecnologías médicas avanzadas, estará presentándose en el Planet MicroCap Showcase: VANCOUVER 2024 en asociación con Small Cap Discoveries el jueves 26 de septiembre de 2024, a las 10:00 AM PST. Brent Ashton, CEO de Covalon, será el encargado de la presentación y responderá preguntas.

La presentación en vivo se podrá acceder a través de webcast en https://www.webcaster4.com/Webcast/Page/3056/510941. Las reuniones uno a uno se llevarán a cabo en persona en el Fairmont Waterfront Vancouver. Si no se puede asistir en vivo, la presentación estará disponible en la plataforma del evento de la conferencia bajo la pestaña 'Agenda' en https://planetmicrocapshowcase.com/agenda.

코발론 테크놀로지스 (TSXV:COV, OTCQX:CVALF), 첨단 의료 기술 회사가 플래닛 마이크로캡 쇼케이스: 밴쿠버 2024에 Small Cap Discoveries와 함께 발표할 예정입니다. 발표는 2024년 9월 26일 목요일 오전 10시 PST에 진행됩니다. 브렌트 애쉬튼 코발론 CEO가 발표를 주최하고 질문에 답변합니다.

실시간 발표는 https://www.webcaster4.com/Webcast/Page/3056/510941를 통해 웹캐스트로 접근할 수 있습니다. 일대일 회의는 페어몬트 워터프론트 밴쿠버에서 직접 진행됩니다. 현장 참석이 불가능한 경우, 발표는 https://planetmicrocapshowcase.com/agenda의 '의제' 탭 아래에서 콘퍼런스 이벤트 플랫폼에서 제공됩니다.

Covalon Technologies (TSXV:COV, OTCQX:CVALF), une entreprise de technologies médicales avancées, présentera au Planet MicroCap Showcase : VANCOUVER 2024 en association avec Small Cap Discoveries le jeudi 26 septembre 2024, à 10h00 PST. Brent Ashton, Directeur général de Covalon, animera la présentation et répondra aux questions.

La présentation en direct pourra être consultée en streaming à l'adresse https://www.webcaster4.com/Webcast/Page/3056/510941. Des réunions individuelles seront organisées en personne au Fairmont Waterfront Vancouver. Si vous ne pouvez pas assister en direct, la présentation sera disponible sur la plateforme de l'événement de la conférence sous l'onglet 'Agenda' à l'adresse https://planetmicrocapshowcase.com/agenda.

Covalon Technologies (TSXV:COV, OTCQX:CVALF), ein Unternehmen für fortschrittliche Medizintechnologien, wird beim Planet MicroCap Showcase: VANCOUVER 2024 in Zusammenarbeit mit Small Cap Discoveries am Donnerstag, den 26. September 2024, um 10:00 Uhr PST präsentieren. Brent Ashton, CEO von Covalon, wird die Präsentation leiten und Fragen beantworten.

Die Live-Präsentation ist über ein Webcast unter https://www.webcaster4.com/Webcast/Page/3056/510941 zugänglich. Einzelgespräche finden persönlich im Fairmont Waterfront Vancouver statt. Wenn eine Teilnahme vor Ort nicht möglich ist, wird die Präsentation auf der Konferenz-Event-Plattform im Bereich 'Agenda' unter https://planetmicrocapshowcase.com/agenda verfügbar sein.

Positive
  • None.
Negative
  • None.

MISSISSAUGA, ON / ACCESSWIRE / September 19, 2024 / Covalon Technologies Ltd., ("Covalon"), (TSXV:COV)(OTCQX:CVALF), an advanced medical technologies company, today announced that it will be presenting and participating in meetings at the Planet MicroCap Showcase: VANCOUVER 2024 in association with Small Cap Discoveries on Thursday, September 26, 2024 at 10:00 AM (Local Time -PST). Brent Ashton, CEO of Covalon, will be hosting the presentation and answering questions at the conclusion.

To access the live presentation, please use the following information:

Planet MicroCap Showcase: VANCOUVER 2024 in association with Small Cap Discoveries

Date: Thursday, September 26, 2024

Time: 1:00 PM Eastern Time (10:00 AM Pacific Time)

Webcast: https://www.webcaster4.com/Webcast/Page/3056/51094

1x1 meetings will be scheduled and conducted in person at the conference venue: Fairmont Waterfront Vancouver.

The Planet MicroCap Showcase: VANCOUVER 2024 website is available here: https://planetmicrocapshowcase.com/

If you can't make the live presentation, Covalon's presentation will be available directly on the conference event platform on this link under the tab "Agenda": https://planetmicrocapshowcase.com/agenda

About Covalon

Covalon is a patient-driven medical device company, that provides innovative and cost-effective healthcare solutions for advanced wound care, infection control, and medical device coatings. Through a strong portfolio of patented technologies and solutions, we offer innovative, gentle and more compassionate options to aid patients on their healing journey. Our solutions are designed for patients and made for care providers. Covalon leverages its patented medical technology platforms and expertise in two ways: (i) by developing products that are sold under Covalon's name; and (ii) by developing and commercializing medical products for other medical companies under development and license contracts. The Company is listed on the TSX Venture Exchange, having the symbol COV and trades on the OTCQX Market under the symbol CVALF. To learn more about Covalon, visit our website at www.covalon.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may contain forward-looking statements which reflect the Company's current expectations regarding future events. The forward-looking statements are often, but not always, identified by the use of words such as "seek", "anticipate", "plan, "estimate", "expect", "intend", or variations of such words and phrases or state that certain actions, events, or results "may", "could", "would", "might", "will" or "will be taken", "occur", or "be achieved". In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts, but instead represent management's expectations, estimates, and projections regarding future events. Forward-looking statements involve risks and uncertainties, including, but not limited to, the factors described in greater detail in the "Risks and Uncertainties" section of our management's discussion and analysis of financial condition and results of operations for the year ended September 30, 2023, which is available on the Company's profile at www.sedarplus.ca, any of which could cause results, performance, or achievements to differ materially from the results discussed or implied in the forward-looking statements. Investors should not place undue reliance on any forward-looking statements. The forward-looking statements contained in this news release are made as of the date of this news release, and the Company assumes no obligation to update or alter any forward-looking statements, whether as a result of new information, further events, or otherwise, except as required by law.

About Planet MicroCap

Planet MicroCap is a global multimedia financial news, publishing and events company focused on news dissemination, providing information, data and analytics for the MicroCap investing community. We have cultivated an active and engaged audience of folks that are interested in learning about and to stay ahead of the curve in the MicroCap space.

If you would like to attend the Planet MicroCap Showcase, please register here: https://planetmicrocapshowcase.com/signup

Investor Relations, Covalon Technologies Ltd.
Email: investors@covalon.com
Website: https://covalon.com/

SOURCE: Covalon Technologies Ltd.



View the original press release on accesswire.com

FAQ

When is Covalon Technologies (CVALF) presenting at the Planet MicroCap Showcase: VANCOUVER 2024?

Covalon Technologies (CVALF) is presenting on Thursday, September 26, 2024, at 10:00 AM PST (1:00 PM EST).

Who will be presenting for Covalon Technologies (CVALF) at the Planet MicroCap Showcase?

Brent Ashton, CEO of Covalon Technologies (CVALF), will be hosting the presentation and answering questions.

How can I access Covalon Technologies 's (CVALF) live presentation at the Planet MicroCap Showcase?

You can access the live presentation via webcast at https://www.webcaster4.com/Webcast/Page/3056/510941.

Where will the one-on-one meetings with Covalon Technologies (CVALF) be held during the Planet MicroCap Showcase?

One-on-one meetings will be conducted in person at the Fairmont Waterfront Vancouver.

Can I view Covalon Technologies 's (CVALF) presentation if I miss the live event?

Yes, the presentation will be available on the conference event platform under the 'Agenda' tab at https://planetmicrocapshowcase.com/agenda.

COVALON TECHS LTD

OTC:CVALF

CVALF Rankings

CVALF Latest News

CVALF Stock Data

58.74M
13.35M
54.08%
Biotechnology
Healthcare
Link
United States of America
Mississauga